Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Optimi Health Corp. (OPTI.CN)
CAD6.50
+0.70 (+12.07%)
CA CNQ Consumer Defensive Agricultural Farm Products
Address
1122 Mainland Street V6B 5L1
Vancouver, BC, CA
Vancouver, BC, CA
CEO
Dane Stevens
Website
optimihealth.ca
IPO
2021-02-25
ISIN CA68405H3080
Also trades on
Canadian Securities Exchange · OPTI.CN (CAD)
NASDAQ Capital Market · OPTH (USD)
Other OTC · OPTHF (USD)
Description
Optimi Health Corp. focuses on developing an integrated brand of functional mushrooms specifically for the Canadian health and wellness food markets. The company manages the entire process from the cultivation and extraction to the processing and distribution of these mushroom strains. Among the fungi varieties it offers are Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. Incorporated in 2020, the company was initially known as 1251418 BC Ltd. before officially changing its name to Optimi Health Corp. in August of that year. Its operations are headquartered in Vancouver, Canada.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CAD6.50
+0.70 (+12.07%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
9.5K
Beta
1.60
Float Shares
2.39M
Free Float %
74.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +6.36% | +5.81% | -26.13% | -5.75% | -24.07% | -13.23% | +65.66% | +18.84% | -61.50% | -63.56% | -63.56% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
6.50
Ratings Trend (MoM)
| Rating | 2026-05 |
|---|---|
| Strong Buy | 0 |
| Buy | 0 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
Quality scores
Altman Z-Score
-2.59
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Agricultural Farm Products: +8.2%+9.4% ★ Q1'26: +62.5% (vs Q1'25)
-
EPS growth Agricultural Farm Products: +20.0%+42.6% ★ Q1'26: -716.7% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Farm Products: +43.8%-376.1% Q1'26: -346.4% (vs Q1'25)
-
EBIT margin Agricultural Farm Products: +8.1%-746.0% Q1'26: -1,363.7% (vs Q1'25)
-
ROIC Agricultural Farm Products: +6.0%-26.3% Q1'26: -54.3% (vs Q1'25)
-
Share dilution Agricultural Farm Products: +0.0%+7.2% Q1'26: +0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Farm Products: 0.61×-2.99× Q1'26: -1.45× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Sep 2025 actual |
Sep 2026 1 Rev. Ana. 1 EPS Ana. |
Sep 2027 1 Rev. Ana. 1 EPS Ana. |
Sep 2028 1 Rev. Ana. |
|---|---|---|---|---|
| Revenue |
426.3K
est: 231.9K (+83.9%)
|
665.7K
665.7K – 665.7K
+187.1% YoY
|
1.22M
1.22M – 1.22M
+82.7% YoY
|
2.21M
2.21M – 2.21M
+81.4% YoY
|
| EBITDA |
-2.23M
est: -139.1K (-1,503.0%)
|
-399.4K
-399.4K – -399.4K
-187.1% YoY
|
-729.8K
-729.8K – -729.8K
-82.7% YoY
|
-1.32M
-1.32M – -1.32M
-81.4% YoY
|
| EBIT |
-3.18M
est: -139.1K (-2,186.1%)
|
-399.4K
-399.4K – -399.4K
-187.1% YoY
|
-729.8K
-729.8K – -729.8K
-82.7% YoY
|
-1.32M
-1.32M – -1.32M
-81.4% YoY
|
| Net Income |
-3.71M
|
-4.54M
-4.54M – -4.54M
|
-2.05M
-2.05M – -2.05M
+54.9% YoY
|
—
— – —
+100.0% YoY
|
| SGA |
2.72M
est: 5.60M (-51.4%)
|
16.07M
16.07M – 16.07M
+187.1% YoY
|
29.36M
29.36M – 29.36M
+82.7% YoY
|
53.26M
53.26M – 53.26M
+81.4% YoY
|
| EPS |
-1.16
|
-1.42
-1.42 – -1.42
|
-0.64
-0.64 – -0.64
+54.9% YoY
|
—
— – —
+100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-21.27M
OE per share TTM
-6.63
Owner's Yield
-80.53%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
6,004.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-3.5K
Shares Outstanding
3.23M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| John James Wilson | Co-Founder & Chairman | 165.0K | male |
| Bryan Edward Safarik | Co-Founder, Chief Operating Officer & Director | 150.0K | male |
| Jacob Safarik | Interim CFO & Director | 150.0K | male |
| Dane Stevens | Co-Founder, Chief Executive Officer, Chief Marketing Officer & Director | 75.0K | male |
| Ann Little | Human Resources Manager | — | female |
| Leah Hodges | Corporate Secretary | — | female |
| Preston A. Chase | Chief Science Officer | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for OPTI.CN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
